Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Sanofi Pasteur
Woman and Man Max 99 years
Sanofi Pasteur SA
Update Il y a 4 ans
Safety and Immunogenicity of Sanofi Pasteur’s DTaP-IPV-Hep B-PRP-T Combined Vaccine Given as a Primary Series of Vaccination in Infants
To describe the safety and reactogenicity after each and all doses of the study vaccine administered as a 3-dose primary series.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Sanofi Pasteur MSD S.N.C
Update Il y a 4 ans
An Open-label, Multi-centre Study of the Safety of a 2-dose Regimen of a Combined Measles, Mumps, Rubella and Varicella Live Vaccine (ProQuad®) Manufactured with Recombinant Human Albumin (rHA) when administered to Children in their Second Year of Life
To describe the safety profile of a second dose of ProQuad® manufactured with rHA when administered to children in their second year of life
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Sanofi Pasteur MSD S.N.C
Update Il y a 4 ans
A randomised, comparative, multicentre clinical trial of the immunogenicity and safety of Tdap-IPV vaccine (REPEVAX) and a tetanus monovalent vaccine in healthy adults 18 years of age and older
To demonstrate that a booster dose of Tdap-IPV vaccine is as immunogenic as a booster dose Tetanus monovalent vaccine in terms of anti-tetanus seroprotection rate (defined as percentage of subjects wi...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Sanofi Pasteur SA
Update Il y a 4 ans
Immunogenicity of the Inactivated, Split-Virion Influenza Vaccine Administered by the Intradermal Route in Comparison with Intramuscular Vaccination with Vaxigrip® in Adults
To demonstrate that the vaccine administered by the intradermal (ID) route with the new Becton Dickinson (BD) ID system (pre-filled ID system allowing a better ergonomic use) is at least as immunogeni...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Sanofi Pasteur SA
Update Il y a 4 ans
Evaluation of the Cellular, Humoral and Mucosal Immune Response in Adults and Elderly Subjects Vaccinated either with an Inactivated Influenza Vaccine Administered via the Intradermal Route or an Inactivated Influenza Vaccine Administered via the Intramuscular Route
- To describe the cellular immune response per age group (adults or elderly) and vaccine group (ID influenza or IM comparator vaccines) before vaccination, and, 7 days, 10 days, 14 days, 21 days, 180 ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Sanofi Pasteur SA
Update Il y a 4 ans
Immunogenicity and Safety of the Investigational Inactivated, Split-Virion Influenza Vaccine 15 µg Administered by the Intradermal Route in Comparison with the Intramuscular Reference Vaccine Vaxigrip® in 50 to 59 Years old Adults
• To demonstrate that the ID investigational vaccine is at least as immunogenic as the IM reference vaccine in terms of geometric mean titer (GMT) after vaccination. • If non-inferiority is demonstr...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Sanofi Pasteur MSD
Update Il y a 4 ans
An Open-label, Multi-centre, Randomised, Comparative Study of the Immunogenicity and Safety of an Inactivated Split-Virion Influenza Vaccine administered by Intradermal Route (Flu-ID 15μg) versus an Inactivated adjuvanted Influenza Vaccine administered by Intramuscular Route (Addigrip® 15µg) in subjects 65 years of age or older
Immunogenicity To demonstrate that the influenza vaccine administered by intradermal (ID) route at the dose of 15μg is at least as immunogenic as the adjuvanted influenza vaccine administered by intra...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Sanofi Pasteur SA
Update Il y a 4 ans
Lot-to-Lot Consistency Study of the Investigational, Split-virion, Inactivated Influenza Vaccine, Administered by the Intradermal Route in Adults
To demonstrate that the three different industrial lots of the intradermal (ID) investigational vaccine induce an equivalent immune response.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Sanofi Pasteur Limited
Update Il y a 4 ans
Safety and Immunogenicity of ADACEL™ (TdcP Vaccine) Compared with QUADRACEL™ (HCPDT-mIPV Vaccine) as Fifth Dose in Children 4-6 Years of Age
1. To compare the immunogenicity of the tetanus and lower dose diphtheria toxoids of ADACEL™ with QUADRACEL™ when given as a fifth dose. 2. To compare the redness, swelling, pain, and fever rates a...
Country
None
organs
None
Specialty
None
More information
Woman and Man Max 99 years
Sanofi Pasteur
Update Il y a 4 ans
Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Child/Adolescent and Adult Subjects
• To describe the safety profile of QIV compared to TIV.
Country
None
organs
None
Specialty
None
More information
Previous
1
2
3
4
5
6
7
Next